These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2224371)

  • 41. Neuroimaging, cognitive, and pathological changes in dementia of the Alzheimer type (DAT).
    Besson JA; Crawford JR; Parker DM; Ebmeier KP; Gemmell HG; Sharp PF; Best PV; Smith FW
    Psychiatry Res; 1989 Sep; 29(3):447-8. PubMed ID: 2608816
    [No Abstract]   [Full Text] [Related]  

  • 42. Subcortical arteriosclerotic encephalopathy: single photon emission computed tomography-magnetic resonance imaging correlation.
    De Cristofaro MT; Mascalchi M; Pupi A; Nencini P; Formiconi AR; Inzitari D; Dal Pozzo G; Meldolesi U
    Am J Physiol Imaging; 1990; 5(2):68-74. PubMed ID: 2252606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
    Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
    Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
    Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
    J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings].
    Sabri O; Hellwig D; Kaiser HJ; Doherty C; Schneider R; Mull M; Willmes von Hinckeldey KW; Büll U; Thron A; Ringelstein EB
    Nuklearmedizin; 1995 Apr; 34(2):50-6. PubMed ID: 7761273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropsychological differences but comparable regional cerebral blood changes in asymptomatic HIV-1-positive and -negative drug addicts.
    Beldarrain MG; García-Moncó JC; Llorens V; Cortés J; Mayo J
    Eur Neurol; 1994; 34(4):193-8. PubMed ID: 8082677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early hypoperfusion of technetium-99m hexamethylprophylene amine oxime brain single photon emission computed tomography in a patient with carbon monoxide poisoning.
    Choi IS; Lee MS
    Eur Neurol; 1993; 33(6):461-4. PubMed ID: 8307069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebral blood flow in corticobasal degeneration.
    Okuda B; Tachibana H
    Mov Disord; 1995 Nov; 10(6):803. PubMed ID: 8750006
    [No Abstract]   [Full Text] [Related]  

  • 49. Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Kuikka J; Helisalmi S; Hartikainen P; Mannermaa A; Ryynänen M; Riekkinen PSr ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):742-6. PubMed ID: 9647302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HMPAO-SPECT and MRI in acute disseminated encephalomyelitis.
    Broich K; Horwich D; Alavi A
    J Nucl Med; 1991 Oct; 32(10):1897-900. PubMed ID: 1919728
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
    Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
    J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPECT findings on psychosis in Alzheimer's disease.
    Kotrla KJ; Chacko RC; Harper RG; Jhingran S; Doody R
    Am J Psychiatry; 1995 Oct; 152(10):1470-5. PubMed ID: 7573586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The need of appropriate brain SPECT templates for SPM comparisons.
    Morbelli S; Rodriguez G; Mignone A; Altrinetti V; Brugnolo A; Piccardo A; Pupi A; Koulibaly PM; Nobili F
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):89-98. PubMed ID: 18043545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral blood flow imaging with technetium-99m-HMPAO SPECT in a patient with chronic subdural hematoma: relationship with neuropsychological test.
    Isaka Y; Imaizumi M; Itoi Y; Ashida K; Horibe K
    J Nucl Med; 1992 Feb; 33(2):246-8. PubMed ID: 1732447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cerebral SPECT and neuropsychological function in Alzheimer's disease].
    Arbizu J; Larumbe R; Rubio L; Villas A; Martínez-Lage JM; Richter JA
    Rev Med Univ Navarra; 1997; 41(1):12-8. PubMed ID: 9527710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical application of brain perfusion SPECT imaging to dementia].
    Matsuda H
    Rinsho Hoshasen; 1989 Oct; 34(11):1327-35. PubMed ID: 2601094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias.
    Masterman DL; Mendez MF; Fairbanks LA; Cummings JL
    J Geriatr Psychiatry Neurol; 1997 Jan; 10(1):15-21. PubMed ID: 9100154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parkinson's disease dementia: clinical correlates of brain spect perfusion and treatment.
    Kramberger MG; Stukovnik V; Cus A; Repovs G; Tomse P; Meglic NP; Garasević Z; Jensterle J; Pirtosek Z
    Psychiatr Danub; 2010 Sep; 22(3):446-9. PubMed ID: 20856190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.